Launch week offerEnds in00h00m00s

annual Promonthly Pro

Shyamaladevi Babu

Assistant Professor

Chettinad Academy of Research and Education

No Info

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (1)

Abinaya Elango

Associate Professor

Chettinad Academy of Research and Education

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shyamaladevi Babu

Research Interests

Make your next move.

Articles (20)

<i>In Vivo</i> Evaluation of Anti-diabetic Activity of Methanolic Extract of <i>Trillium govanianum</i> Rhizome in Wistar Albino Rats

Nanotechnology‐Based Drug Delivery Systems: Advances and Challenges

Assessment of pain and post-injection induration in children: A comparative study of cold application, manual pressure, and shot blocker techniques

Dual Dietary Assault: Unraveling the Synergistic Impact of High-Fat and High-Sucrose Intake on Type 2 Diabetes Pathogenesis

Liver X receptors as precision therapeutic targets: Redefining metabolic and inflammatory interventions

Melatonin-mediated stress signaling in plants: Multilayered networks and translational potential for climate-resilient agriculture

Phytic Acid as a Functional Nutrient: Unraveling its Role in Type 2 Diabetes Management and Obesity Control

The mechanistic interplay of reactive oxygen species in metabolic pathways and insulin signaling in type 2 diabetes

Are we underestimating cardiovascular risks in midlife women? A call for gender-specific strategies

Comment on: “Pathological primary tumor status, rather than adjuvant therapy, predicts survival outcomes in pT1–3N1M0 oral cavity squamous cell carcinoma: A nationwide cohort study”

Commentary on Lee et al: From crisis to diagnosis: redefining the emergency department's role in head and neck cancer detection

Commentary on “Evaluation of the 10 %-rule in sentinel lymph node biopsy for clinically node-negative oral squamous cell carcinoma”

Commentary on “High expression of H2AX/γ-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinoma”

Commentary on “Life following total laryngectomy: Mixed-model analyses of longitudinal patient-reported outcomes in a prospective cohort”

Commentary on “Mandibular swing approach: 25 years of experience at Istituto Nazionale Tumori of Milan”

Commentary on “Massive nasal bleeding in nasopharyngeal carcinoma: Incidence, risk predictors, and survival impact”

Commentary on “Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment: A multi-institutional study on 406 patients from the ARYFIX collaborative group”

Commentary on: From mutation maps to clinical impact: Unraveling OSCC genomics in a japanese nationwide cohort

Comments on “Towards transcervical ultrasound-guided transoral robotic surgery”

HPV status and staging in oropharyngeal carcinoma: A review of recent AJCC/UICC revisions

Collaborators (1)

Abinaya Elango

Make your next move.